First safety test of 'Off-the-Shelf' immune cells to fight tough leukemia
Disease control
Completed
This early-stage trial tested the safety of a new immune cell therapy for adults with acute myeloid leukemia that has come back or not responded to other treatments. Doctors gave patients natural killer (NK) cells from healthy donors to see if they could help the body fight the c…
Phase: PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC